Request Sample
Request Methodology
Description
Venous Leg Ulcer Treatment Market size was valued at USD 2,851.2 million in 2021, It is growing at a CAGR of 5.3% from 2022 to 2028. Venous leg ulcers are most frequently brought on by infection, although they can also be brought on by diabetes, obesity, and ageing. If left untreated, venous leg ulcers can become exceedingly painful and quickly worsen into more dangerous conditions. Leg ulcers caused by venous blood flow can be treated using a variety of techniques. While some ulcer treatments call for surgery, others call for the use of drugs to aid in ulcer healing. The origin of the ulcer and the patient’s symptoms will determine the best course of treatment for venous leg ulcers. The global market provides a detailed overview and can be segmented by drug class, route of administration, distribution channel, and region. By drug class, the market has been segmented into antibiotics, corticosteroids, monoclonal antibodies, immunosuppressant drugs, and others. By route of administration, the market has been segmented into oral, parenteral, and topical. By distribution channel, the venous leg ulcer treatment market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment continues its dominance during the forecast period share in the market owing to the increase in the hospitalization rate and the rise in hospital healthcare infrastructure.
Key Development:
In June 2019, Milliken & Company acquired Andover Healthcare, a leading manufacturer of cohesive bandages and compression systems with an aim to provide innovative and comprehensive solutions for patient care.
